Home Capital Broker's Calls

Temasek-linked investment keeps Asian Healthcare Specialists at 'buy'

Stanislaus Jude Chan
Stanislaus Jude Chan10/22/2018 11:36 AM GMT+08  • 2 min read
Temasek-linked investment keeps Asian Healthcare Specialists at 'buy'
SINGAPORE (Oct 22): UOB Kay Hian is reiterating its “buy” recommendation on Asian Healthcare Specialists (AHS) with an unchanged target price of 33 cents following the orthopaedic group’s proposed issuance of convertible bond and grant of share opti
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Oct 22): UOB Kay Hian is reiterating its “buy” recommendation on Asian Healthcare Specialists (AHS) with an unchanged target price of 33 cents following the orthopaedic group’s proposed issuance of convertible bond and grant of share option to Temasek Holdings-linked Vanda 1.

Vanda 1 is managed and controlled by Heliconia Capital Management, which is a subsidiary of Temasek.

AHS last week announced it has entered into an investment agreement to issue $5 million in convertible bonds due in 2021 to Vanda 1 at a conversion price of 25 cents per share, and a grant of share options another $5 million worth of shares at an exercise price of 32.5 cents per share.

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.